About
Veracyte Inc (NASDAQ:VCYT) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers
Apr 14 2026
Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026
Mar 16 2026
Veracyte Names Kevin Haas as Chief Development and Technology Officer
Feb 25 2026
Veracyte Announces Fourth Quarter and Full Year 2025 Financial Results
Feb 24 2026
Veracyte to Highlight Extensive Decipher® Data at 2026 ASCO GU Symposium
Financials
Revenue
$517.14 M
Market Cap
$2.56 B
P/E Ratio
39.33
EPS
0.82
Google Übersetzer